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communicate quickly and easily with
provincial and municipal health
authorities was needed to ensure that
the most up-to-date information con-
cerning the outbreak was available.
The intergovernmental relationships
necessary for such rapid communica-
tion should be established in advance.
Third, accurate and timely communi-
cation with frontline staff members is
the best way to minimize their fears.
Finally, personal protective equip-
ment procedures should be main-
tained until assurance that the expo-
sure risk is negligible. The SARS out-
break is unlikely an isolated occur-
rence; therefore, sound advance plan-
ning on the basis of experience will
increase the ability to protect both
EMS staff and the public in the future.
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To the Editor: Two of eight per-
sons with laboratory-confirmed severe
acute respiratory syndrome– associat-
ed coronavirus (SARS-CoV) infection
in the United States during 2003 were
pregnant women. Robertson et al. (1)
reported data describing one pregnant
patient who recovered and delivered a
healthy infant. We report data con-
cerning the second patient, with fol-
low-up 1 month after the child’s birth. 
The patient, a healthy, 38-year-old
woman in the 7th week of pregnancy,
traveled with her husband to Hong
Kong. From March 1 to March 6,
2003, they stayed at the Hong Kong
hotel where it is believed a physician
from China spread SARS-CoV to sev-
eral guests. These guests were the
index case-patients for subsequent
outbreaks in Hong Kong, Vietnam,
Singapore, and Toronto, Canada (2).
The woman and her husband returned
to the United States on March 6; the
husband had onset of SARS illness on
March 13. On March 19, the patient
had onset of an illness with fever (tem-
perature 37.8–40°C), muscle aches,
chills, headache, runny nose, produc-
tive cough, wheezing, and shortness of
breath. A chest radiograph showed a
diffuse infiltrate in the left lung. The
patient was hospitalized for 9 days and
given broad-spectrum antimicrobial
drugs. She recovered from her illness,
and enzyme immunoassay and
immunofluorescent assays conducted
on serum samples on days 28 and 64
after illness onset were positive for
antibodies to SARS-CoV.
The patient had an uneventful
pregnancy until the last trimester,
when her blood glucose levels were
elevated. Early spontaneous rupture
of membranes initiated preterm labor,
and a cesarean section was performed
at 36 weeks’ gestation because of fetal
distress. A 5-pound, 7-ounce, healthy
boy was delivered without complica-
tions. Apgar scores were 7 at 1 minute
and 8 at 5 minutes. The newborn had
no illness, abnormalities, or congeni-
tal malformations. Serum samples
from the patient at delivery were pos-
itive for antibodies to SARS-CoV, but
cord blood and placenta samples were
negative. Breast milk samples on
postpartum days 12 and 30 were also
negative for SARS-CoV antibodies.
Blood, stool, and nasopharyngeal
swab samples from the patient and
cord-blood samples showed no viral
RNA by reverse transcription–poly-
merase chain reaction. Stool samples
from the newborn, collected on days
12 and 30 after delivery, were also
negative for viral RNA.
Although other countries have
reported cases of severe illness and
poor outcome associated with SARS-
CoV infection during pregnancy
(3–5), neither of the two pregnant
SARS case-patients in the United
States had serious adverse outcomes.
The presence of antibodies to SARS-
CoV in breast milk might be influ-
enced by the time of infection in rela-
tion to gestation. Robertson et al. (1)
reported that antibodies to SARS-CoV
were detected in the breast milk of a
patient who was infected at 19 weeks’
gestation; however, the patient in this
case was infected at 7 weeks’ gesta-
tion, and antibodies to the virus were
not detected in her breast milk. No
reports have indicated vertical trans-
mission of SARS-CoV, a finding that
is supported by our data. However, too
few cases have been studied to clearly
define the risks and provide guidance
for treating pregnant women infected
with SARS CoV.
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To the Editor: Moore et al. report-
ed a case series of patients infected
with imported gnathostomiasis who
had typical intermittent, migratory
skin manifestations or peripheral
blood eosinophilia or both, as well as
undiagnosed eosinophilia with non-
specific symptoms (1). We would like
to add some comments based on a
recent patient treated in Marseille,
France.
In April 2003, a 66-year-old man
living in Marseille indicated a history
of fever for 8 days. He had returned
from Vietnam 1 month earlier, where
he had stayed for 4 weeks in the Ho
Chi Minh City area and 2 days in the
Mekong Delta area. He was well dur-
ing his trip, and reported no arthropod
bites except from mosquitoes. He had
no direct skin contact with river water.
Dietary intake included local dishes
with rice, fish, pork, shrimp, and
chicken. His symptoms started 3
weeks after he returned to Marseille
and included fever (temperature
38°C), asthenia, chills (1 day), moder-
ate dyspnea during exercise, transient
bilateral pain of the testes, and an
episode of hemospermia. He was
referred by his family doctor to the
Infectious and Tropical Diseases Unit,
North Hospital. 
On admission, the patient’s temper-
ature was 38°C. Physical examination
of the patient, including the testes, was
normal except for a systolic heart mur-
mur (preexisting and known to the
patient), and clinical signs of left pleu-
ral effusion. The effusion was subse-
quently confirmed by chest x-ray,
which also showed a discrete diffuse
bilateral lung infiltrate. Results of rou-
tine laboratory tests conducted on
blood samples were normal except for
an elevated eosinophil count of 5.2
109/L. Blood smears for plasmodia
and microfilaremia were negative.
Urologic examination, including
echography and prostate-specific anti-
gen, showed no abnormalities except a
prostatic adenoma (preexisting and
known to the patient). No eggs or par-
asites were detected by microscopic
examination in stools or in urine,
although both sedimented and cen-
trifuged urine specimens were studied
and filtration techniques were used.
After transthoracic aspiration of 100
mL of pleural effusion, cytologic
examination showed an eosinophil
count of 5,800/L without parasites.
Bacterial culture, including mycobac-
teria, was negative. On day 4, the
patient was afebrile and was dis-
charged. On admission, results of a
first set of examinations involving
reactivities to schistosomiasis, parago-
nimiasis, strongyloidiasis, cysticerco-
sis, trichinosis, gnathostomiasis, filari-
asis, and toxocariasis were negative.
One month later, the eosinophil
count of our patient had decreased to
1.8 x 109/L. He was afebrile, and his
only complaint was asthenia. A new
set of serologic examinations was
conducted. The Western blot assay for
gnathostomiasis conducted at the
Swiss Tropical Institute (Socinstrasse
57, CH-4002, Basel, Switzerland) was
positive, showing immunoglobulin G
reactivity to four specific bands
including the 24-kDa band, consid-
ered pathognomonic for the diagnosis
of Gnathostoma infection (1). The
seroconversion confirmed the diagno-
sis of gnathostomiasis. All other sero-
logic tests remained negative, except
an increase of antibodies against
Acanthocheilonema vitae used as
antigen for unspecific serologic
screening for filariasis (Laboratoire
Marcel Merieux, Lyon, France). After
a 21-day course of albendazole and a
single dose of ivermectin, the
eosinophil count of our patient
decreased to 0.8 x 109/L.
Three aspects of gnathostomiasis
as an emerging imported disease can
complement the findings of Moore et
al. (1). First, the clinical findings in
our case are very unusual. Hemo-
spermia is often benign with predomi-
nant causes including prostatic and
seminal vesicle disease. Infections,
including mainly schistosomiasis and
tuberculosis, have been associated
with these symptoms (2). Although
our patient had a prostatic adenoma,
this is the first time that hemospermia
has been associated with gnathostomi-
asis. Because of the anxiety hemosper-
mia caused, this symptom was the
main reason that our patient consulted
our center. Secondly, eosinophilic
pleural effusion is also unusual in
gnathosthosmiasis. Although reported
as a potential cause in reference books
(3), a Medline search (key words:
gnathostomiasis and eosinophilia and
pleural effusion or pleuritis or lung)
disclosed only two references to pleu-
ral  effusion as the main symptom of
gnathostomiasis (4,5). 
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